PharmaEngine, Inc. (TPEX:4162)
Taiwan · Delayed Price · Currency is TWD 63.10
-0.60 (-0.94%)
Aug 6, 2026, 10:50 AM CST
PharmaEngine Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 963.83 | 911.42 | 2,523 | 767.67 | 654.38 | 654.84 |
Revenue Growth | -62.15% | -63.88% | 228.70% | 17.31% | -0.07% | -37.99% |
Gross Profit Gross Profit Growth | 909.13 | 859.56 | 2,476 | 718.97 | 604.68 | 617.76 |
Operating Income Operating Income Growth | 466.57 | 425.46 | 2,053 | 277.18 | 282.74 | 362.69 |
Net Income Net Income Growth | 422.55 | 387.64 | 1,751 | 274.65 | 318.78 | 426.03 |
Earnings Per Share EPS Growth | 2.93 | 2.69 | 12.17 | 1.91 | 2.22 | 2.94 |
EPS Growth | -76.19% | -77.90% | 537.17% | -13.96% | -24.49% | -28.99% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,975 | 4,717 | 3,861 | 3,628 | 3,661 | 3,814 |
Total Debt Total Debt Growth | 39.96 | 42.12 | 7.14 | 14.81 | 22.35 | 7.59 |
Net Cash (Debt) Net Cash Growth | 4,935 | 4,675 | 3,854 | 3,613 | 3,639 | 3,806 |
Net Cash Growth | -12.81% | 21.30% | 6.65% | -0.71% | -4.39% | 12.88% |
Net Cash Per Share Net Cash Per Share Growth | 34.29 | 32.48 | 26.78 | 25.14 | 25.32 | 26.30 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 178.47 | 1,727 | 456.73 | 256.97 | 202.01 | 929.67 |
Capital Expenditures CapEx Growth | -0.28 | -0.28 | -0.81 | -0.41 | -3.44 | -0.23 |
Free Cash Flow Free Cash Flow Growth | 178.19 | 1,727 | 455.92 | 256.56 | 198.57 | 929.44 |
Free Cash Flow Growth | -91.83% | 278.70% | 77.71% | 29.20% | -78.64% | 1335.01% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 94.32% | 94.31% | 98.11% | 93.66% | 92.41% | 94.34% |
Operating Margin | 48.41% | 46.68% | 81.37% | 36.11% | 43.21% | 55.39% |
Pretax Margin | 57.29% | 55.88% | 85.72% | 44.03% | 59.97% | 83.29% |
Profit Margin | 43.84% | 42.53% | 69.39% | 35.78% | 48.72% | 65.06% |
FCF Margin | 18.49% | 189.44% | 18.07% | 33.42% | 30.34% | 141.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 6.000 | 1.500 | 2.000 | 2.700 |
Dividend Per Share Growth | -66.67% | -66.67% | 300.00% | -25.00% | -25.93% | 8.00% |
Dividend Yield | 3.17% | 2.84% | 7.20% | 1.57% | 1.81% | 4.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 21.74 | 26.09 | 7.41 | 55.19 | 56.34 | 23.96 |
Forward PE | - | 26.00 | 10.91 | 42.71 | 150.60 | 28.38 |
P/FCF Ratio | 51.36 | 5.86 | 28.46 | 59.08 | 90.45 | 10.98 |
PS Ratio | 9.50 | 11.10 | 5.14 | 19.75 | 27.45 | 15.59 |